Clinical Performance of the Diassess Influenza A and B Test
NCT ID: NCT03035396
Last Updated: 2018-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
567 participants
INTERVENTIONAL
2016-12-29
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
NCT01753531
Influenza in People With Normal and Weakened Immune Systems
NCT00533182
Influenza A+B Test Kit Performance Study
NCT03895268
Prospective Evaluation of the Fluid Rapid Influenza Test
NCT00826709
Clinical Validation of the Point-of-Care MSD Influenza Test
NCT00863343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diassess Influenza A and B Test
Diassess Influenza A and B Test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diassess Influenza A and B Test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has at least one additional flu-like symptom including fever or feeling feverish/chills, runny or stuffy nose, muscle or body aches, fatigue (very tired), sore throat, headaches, or cough
Exclusion Criteria
* Subject has been taking or took any antivirals for influenza in the past 30 days
* Subject enrolled in any drug trials
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diassess Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carol Chen, PhD
Role: STUDY_DIRECTOR
Diassess Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Health Care Center
Syracuse, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIA 01A-CLI-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.